OneOncology Presents Abstracts at ASCO Highlighting Importance of Increasing NGS Testing

/PRNewswire/ -- At the 2023 ASCO annual meeting, investigators from OneOncology's clinical team will present Oral Abstracts using real-world data to evidence...

Related Keywords

New York ,United States ,Los Angeles ,California ,Tennessee ,Connecticut ,Gregory Vidal ,Eric Hoffman ,Thomas Stricker ,Community Practice ,Research Led ,Los Angeles Cancer Network ,Breast Cancer Disease Group ,Community Setting ,Roche Group ,Research Institute ,Cancer Center Research Institute ,Genentech ,Flatiron Health ,Cancer Center ,Eastern Connecticut Hematology Oncology Associates ,Clinical Research ,Health Services Research ,Research Presented ,Targeted Treatment ,Gregory Vidal Evidences Identifies Inequities ,Provider Levelsin Accessing ,Among Black ,Oral Abstracts ,Non Small Cell Lung Cancer ,Next Generation Sequencing ,Medical Director ,Precision Medicine ,Clinical Value ,Timely Treatment ,Advanced Non Small Cell Lung Cancer Patients ,Actionable Driver Oncogenes ,Practice And Provider Level Inequities ,Next Generation Sequencing Testing ,West Cancer Center ,Non Small Cell Lung ,Mary Bird Perkins ,Eastern Connecticut Hematology ,Oncology Associates ,New York Cancer ,Blood Specialists ,Astera Cancer Care ,Services Research ,Oneoncology ,